<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/espr" ></link>
<id>urn:uuid:61c7d1de-bea7-92fb-b97e-4ea2021356d9</id>
<updated>2026-05-02T15:49:42-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ESPR: LOOKER BENJAMIN (LO) Sold (S) 5,708 Shares of ESPERION THERAPEUTICS INC for $2.70 on 3/17</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6368893" ></link>
<id>urn:uuid:f2ac0fc3-f276-0f9b-59a4-5eddb98c058d</id>
<updated>2026-03-18T16:13:45-04:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
<entry>
<title>ESPR: KOENIG SHELDON L (PR,CEO,DIR) Sold (S) 25,578 Shares of ESPERION THERAPEUTICS INC for $2.72 on 3/17</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6368890" ></link>
<id>urn:uuid:11ba5e13-4923-0c82-ee83-7b4d2fc1e78b</id>
<updated>2026-03-18T16:13:23-04:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
<entry>
<title>ESPR: HALLADAY BENJAMIN (CFO) Sold (S) 6,424 Shares of ESPERION THERAPEUTICS INC for $2.70 on 3/17</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6368891" ></link>
<id>urn:uuid:5f687a37-2c96-4df8-f03a-52571c1d0d19</id>
<updated>2026-03-18T16:12:52-04:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
<entry>
<title>ESPR: LOOKER BENJAMIN (LO) Acquired (JB) 300,840 Shares of ESPERION THERAPEUTICS INC for $0.00 on 3/13</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6363130" ></link>
<id>urn:uuid:cbf637cb-6d4e-aa15-18b7-ab783cc6eeee</id>
<updated>2026-03-16T16:20:52-04:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
<entry>
<title>ESPR: KOENIG SHELDON L (PR,CEO,DIR) Acquired (JB) 723,760 Shares of ESPERION THERAPEUTICS INC for $0.00 on 3/13</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6363117" ></link>
<id>urn:uuid:1f3a49ef-7cd1-296d-9135-099d5ad3342b</id>
<updated>2026-03-16T16:20:30-04:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
<entry>
<title>ESPR: HALLADAY BENJAMIN (CFO) Acquired (JB) 247,430 Shares of ESPERION THERAPEUTICS INC for $0.00 on 3/13</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6363100" ></link>
<id>urn:uuid:ef82d692-ecd0-36f6-0e95-e91844d722f8</id>
<updated>2026-03-16T16:19:29-04:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
<entry>
<title>ESPR: LOOKER BENJAMIN (GC) Sold (S) 1,689 Shares of ESPERION THERAPEUTICS INC for $2.88 on 1/20</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6310964" ></link>
<id>urn:uuid:1a1f6490-cc59-bc66-8907-37f8926f1f04</id>
<updated>2026-01-21T17:17:27-05:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
<entry>
<title>ESPR: KOENIG SHELDON L (PR,CEO,DIR) Sold (JS*) 48,244 Shares of ESPERION THERAPEUTICS INC for $3.67 on 12/17</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6295155" ></link>
<id>urn:uuid:f52bb192-39d6-31a7-2c26-d95fab0c43fb</id>
<updated>2025-12-18T16:10:00-05:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
<entry>
<title>ESPR: HALLADAY BENJAMIN (CFO) Sold (JS*) 7,337 Shares of ESPERION THERAPEUTICS INC for $3.67 on 12/17</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6295143" ></link>
<id>urn:uuid:cdfb990c-cd02-609c-d0e1-c757a33d16b7</id>
<updated>2025-12-18T16:09:36-05:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
<entry>
<title>ESPR: LOOKER BENJAMIN (GC) Sold (JS*) 6,517 Shares of ESPERION THERAPEUTICS INC for $3.67 on 12/17</title>
<link href="http://www.insiderinsights.com/company/espr/esperion-therapeutics-inc/id-6295146" ></link>
<id>urn:uuid:20009032-32d8-2bb0-dcfa-2e6ed1a299b0</id>
<updated>2025-12-18T16:09:13-05:00</updated>
<summary type="html" ><![CDATA[ESPERION THERAPEUTICS INC (ESPR). Recent Price: $1.98. Mkt Cap:509.7mm. 10D Vol: 7.3mm]]></summary>
</entry>
</feed>